Other Forms of Transmission

American Trypanosomiasis

Volumn , Issue , 2010, Pages 583-597

  Hontebeyrie, Mireille ^a   Brenière, Simone Frédérique ^b   Aznar, Christine ^c  

^a INSTITUT PASTEUR   (France)

^b INSTITUT DE RECHERCHE POUR LE DÉVELOPPEMENT   (France)

^c UNIVERSITÉ DES ANTILLES ET DE LA GUYANE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84882441810     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-12-384876-5.00023-X     Document Type: Chapter

References (108)

1. Altclas J., Sinagra A., Dictar M., Luna C., Veron M.T., De Rissio A.M., et al. Chagas disease in bone marrow transplantation: an approach to preemptive therapy. Bone Marrow Transplant. 2005, 36(2):123-129.
2. Añez N., Carrasco H., Parada H., Crisante G., Rojas A., Gonzalez N., et al. Acute Chagas' disease in western Venezuela: a clinical, seroparasitologic, and epidemiologic study. Am. J. Trop. Med. Hyg. 1999, 60:215-222.
3. Appleman M.D., Shulman I.A., Saxena S., Kirchhoff L.V. Use of a questionnaire to identify potential blood donors at risk for infection with Trypanosoma cruzi. Transfusion 1993, 33:61-64.
4. Avila H.A., Borges-Pereira J., Thiemann O., de Paiva E., Degrave W., Morel C.M., et al. Detection of Trypanosoma cruzi in blood specimens of chronic chagasic patients by polymerase chain reaction amplification of kinetoplast minicircle DNA: comparison with serology and xenodiagnosis. J. Clin. Microbiol. 1993, 31:2421-2426.
5. Aznar C., Liegeard P., Mariette C., Lafon S., Levin M.J., Hontebeyrie M. A simple Trypanosoma cruzi enzyme-linked immunoassay for control of human infection in nonendemic areas. FEMS Immunol. Med. Microbiol. 1997, 18:31-37.
6. Aznar C., La Ruche G., Laventure S., Carme B., Liegeard P., Hontebeyrie M. Seroprevalence of Trypanosoma cruzi infection in French Guiana. Mem. Inst. Oswaldo Cruz 2004, 99(8):805-808.
7. Baretto M.P., Ribeiro R.D., Belda Neto F.M. Estudos sobre reservatórios e vectores silvestres do Trypanosoma cruzi. LXVIII: infeccão de mamiferos pela via oral. Rev. Bras. Biol. 1978, 38:455-469.
8. Bern C., Montgomery S.P., Herwaldt B.L., Rassi A., Marin-Neto J.A., Dantas R.O., et al. Evaluation and treatment of Chagas disease in the United States. JAMA 2007, 298(18):2171-2182.
9. Bestetti R.B., Theodoropoulos T.A.D. A systematic review of studies on heart transplantation for patients with end-stage Chagas' heart disease. J. Card. Fail. 2009, 15(3):249-255.
10. Bocchi E.A., Fiorelli A. The paradox of survival results after heart transplantation for cardiomyopathy caused by Trypanosoma cruzi. Ann. Thorac. Surg. 2001, 71:1833-1838.
11. Brener Z. Laboratory-acquired Chagas' disease: an endemic disease among parasitologists. Genes and Antigens of Parasites: A Laboratory Manual 1984, 3-9. Fundaçao Oswaldo Cruz, Rio de Janeiro, Brazil. second ed. C.M. Morel (Ed.).
12. Brenière F., Poch O., Selaès H., Tibayrenc M., Lemesre J.L., Antezana G., et al. Specific humoral depression in chronic patients infected with Trypanosoma cruzi. Rev. Inst. Med. Trop. São Paulo 1984, 26:254-258.
13. Brenière S.F., Bosseno M.F., Noireau F., Yacsik N., Liegeard P., Aznar C., et al. Integrate study of a Bolivian population infected by Trypanosoma cruzi, the agent of Chagas disease. Mem. Inst. Oswaldo Cruz 2002, 97(3):289-295.
14. Brumpt E. Précis de Parasitologie 1927, Masson et Cie, Paris, p. 236.
15. Calvo M.M.L., Nogueda B., Aguilar R.A. Oral route: a probable way of transmission of Trypanosoma cruzi. Rev. Lat-amer. Microbiol. 1992, 34:39-42.
16. Camandaroba E.L.P., Pinheiro Lima C.M., Andrade S.G. Oral transmission of Chagas disease: importance of Trypanosoma cruzi biodeme in the intragastric experimental infection. Rev. Inst. Med. Trop. São Paulo 2002, 44(2):97-103.
17. Cardoso A.V.N., Lescano S.A.Z., Amato Neto V., Gakiya E., Santos S.V. Survival of Trypanosoma cruzi in sugar cane used to prepare juice. Rev. Inst. Med. Trop. São Paulo 2006, 43(3):161-162.
18. Carvalho M.R., Krieger M.A., Oeleman W., Shikanai-Yasuda M.A., Ferreira A.W., Pereira J.B., et al. Chagas' disease diagnosis: evaluation of several tests in blood bank screening. Transfusion 1993, 33:830-834.
19. Cimo P., Luper W., Scouros M. Transfusion-associated Chagas' disease in Texas: report of a case. Tex. Med. 1993, 89:48-50.
20. Coudert J., Despeignes J., Battesti M.R., Michel-Brun J. Un cas de maladie de Chagas par contamination accidentelle de laboratoire avec T. cruzi. Soc. Pathol. Exot. 1964, 57:208-213.
21. Coura J.R., Junqueira A.C.V., Fernandes O., Valente S.A.S., Miles M.A. Emerging Chagas disease in Amazonian Brazil. Trends Parasitol. 2002, 18(4):171-176.
22. D'Albuquerque L.A., Gonzalez A.M., Filho H.L., Copstein J.L., Larrea F.I., Mansero J.M., et al. Liver transplantation from deceased donors serologically positive for Chagas disease. Am. J. Transplant. 2007, 7(3):680-684.
23. Degrave W., Fragoso S.P., Britto C., Van-Heuverswyn H., Kidane G.Z., Cardoso M.A., et al. Peculiar sequence organization of kinetoplast DNA minicircles from Trypanosoma cruzi. Mol. Biochem. Parasitol. 1988, 27:63-70.
24. Dias, E., 1933. Estudos sobre o Schizotrypanum cruzi (tesis doctoral). Universidade de Rio de Janeiro, Rio de Janeiro.
25. Dias, E., 1935. Xenodiagnóstico e algumas verificações epidemiológicas na moléstia de Chagas. In: Reunião da Sociedade de Patologia Regional, Buenos Aires, 1, 89-119.
26. Dias J.P., Bastos C., Araujo E., Mascarenhas A.V., Netto E.M., Grassi F., et al. Acute Chagas disease outbreak associated with oral transmission. Rev. Soc. Bras. Med. Trop. 2008, 41(3):296-300.
27. Diaz-Ungria C. Transmision del Trypanosoma cruzi en los vertebrados. Rev. Ibér. Parasitol. 1965, 25:1-44.
28. Diez M., Favaloro L., Bertolloti A., Burgos J.M., Vigiliano C., Lastra M.P., et al. Usefulness of PCR strategies for early diagnosis of Chagas' disease reactivation and treatment follow up in heart transplantation. Am. J. Transplant. 2007, 7:1633-1640.
29. Di Pentima M.C., Hwang L.Y., Skeeter C.M., Edwards M.S. Prevalence of antibody to Trypanosoma cruzi in pregnant Hispanic women in Houston. Clin. Infect. Dis. 1999, 28:1281-1285.
30. El Ghouzzi M.-H., Boiret E., Wind F., Brochard C., Fittere S., Paris L., et al. Testing blood donors for Chagas disease in the Paris area, France: first results after 18 months of screening. Transfusion 2009, 7(10):1223-1234.
31. Ferreira C.A., Martinho P.C., Amato Neto V., Cruz R.R.B. Pasteurization of human milk to prevent transmission of Chagas disease. Rev. Inst. Med. Trop. São Paulo 2001, 43(3):161-162.
32. Ferreira M.S., Nishioka S.A., Silvestre M.T., Borges A.S., Nunes-Araujo F.R., et al. Reactivation of Chagas' disease in patients with AIDS: report of three new cases and review of the literature. Clin. Infect. Dis. 1997, 25:1397-1400.
33. Floch H., Camaim R. Deux nouveaux cas de maladie de Chagas en Guyane Française. Bull. Soc. Path. Exot. 1948, 47:22-25.
34. Floch H., Tasque P. Un cas de maladie de Chagas en Guyane Française. Bull. Soc. Path. Exot. 1941, 36:37.
35. Flores-Chavez M., Fernandez B., Puente S., Torres P., Rodríguez M., Monedero C., et al. Transfusional Chagas disease: parasitological and serological monitoring of an infected recipient and blood donor. Clin. Infect. Dis. 2008, 46:44-47.
36. Forés R., Sanjuán I., Portero F., Ruiz E., Regidor C., López-Vélez R., et al. Chagas disease in a recipient of cord blood transplantation. Bone Marrow Transplant. 2007, 39(2):127-128.
37. Frank M., Hegenscheid B., Janitschke K., Weinke T. Prevalence and epidemiological significance of Trypanosoma cruzi infection among Latin American immigrants in Berlin, Germany. Infection 1997, 25:355-358.
38. Freitas H.F., Chizzola P.R., Paes A.T., Lima A.C., Mansur A.J. Risk stratification in a Brazilian hospital-based cohort of 1220 outpatients with heart failure: role of Chagas' heart disease. Int. J. Cardiol. 2005, 102:239-247.
39. Galel S.A., Kirchhoff L.V. Risk factor for Trypanosoma cruzi infection in California blood donors. Transfusion 1996, 36:227-231.
40. Galel S.A., Lifson J.D., Engleman E.G. Prevention of AIDS transmission through screening of the blood supply. Ann. Rev. Immunol. 1995, 13:201-227.
41. Gascon J., Bern C., Pinazo M.J. Chagas disease in Spain, the United States and other non-endemic countries. Acta. Trop. 2009, 115:22-27.
42. Gomes M.L., Galvao M.C., Macedo A.M., Pena S.D.J., Chiari E. Chagas' disease diagnosis: comparative analysis of parasitologic, molecular, and serological methods. Am. J. Trop. Med. 1999, 60:205-210.
43. Grant I.H., Gold J.W.M., Wittner M., Tanovitz H.B., Nathan C., Mayer K., et al. Transfusion-associated acute Chagas' disease acquired in the United States. Ann. Intern. Med. 1989, 111:849-851.
44. Guerri-Guttenberg R.A., Ciannameo A., Di Girolamo C., Milei J.J. Chagas disease: an emerging public health problem in Italy?. Infec. Med. 2009, 17:5-13.
45. Herwaldt B.L. Laboratory-acquired parasitic infections from accidental exposures. Clin. Microbiol. Rev. 2001, 14(4):659-688.
46. Hofflin J.M., Sadler R.H., Araujo F.J., Page W.E., Remington J.S. Laboratory-acquired Chagas' disease. Trans. R. Soc. Trop. Med. Hyg. 1987, 81:437-440.
47. Jansen, A.M., Deane, M.P., 1985. Trypanosoma cruzi infection of mice by ingestion of food contaminated with material of the anal gland of opossum Didelphis marsupialis. In: Reunião sobre Pesquisa Básica em Doenças de Chagas, 12. Caxambu, MG, p. 39.
48. Jost L., Turin M., Etchegoyen F., Leiguarda R., Taratuto A.L., Iotti R. Meningoencefalitis chagasica en paciente con tratamiento inmunosupresor por transplante renal. Rev. Neurol. Arg. 1977, 3:425L-428L.
49. Kerleguer A., Massard S., Janus G., Joussemet M. La maladie de Chagas: évaluation des tests de dépistage au centre de transfusion sanguine des armées, prévalence dans les armées (Chagas disease: screening tests evaluation in a blood military center, prevalence in the French Army). Pathol. Biol. 2007, 55:534-538.
50. Kerndt P.R., Waskin H.A., Kirchhoff L.V., Steurer F., Waterman S.H., Nelson J.M., et al. Prevalence of antibody to Trypanosoma cruzi among blood donors in Los Angeles, California. Transfusion 1991, 31:814-818.
51. Kirchhoff L.V., Paredes P., Lomeli-Guerrero A., Paredes-Espinoza M., Ron-Guerrero C.S., Delgado-Mejia M., et al. Transfusion-associated Chagas disease (American trypanosomiasis) in Mexico: implications for transfusion medicine in the United States. Transfusion 2006, 46:298-304.
52. Kohl S., Pickering L.K., Frankel L.S., Yaeger R.G. Reactivation of Chagas' disease during therapy of acute lymphocytic leukemia. Cancer 1982, 50:827-828.
53. Kun H., Moore A., Mascola L., Steurer F., Lawrence G., Kubak B., et al. Transmission of Trypanosoma cruzi by heart transplantation. Clin. Infect. Dis. 2009, 48:1534-1540.
54. Leiby D.A., Lenes B.A., Tibbals M.A., Tames-Olmedo M.T. Prospective evaluation of a patient with Trypanosoma cruzi infection transmitted by transfusion. N. Engl. J. Med. 1999, 341:1237-1239.
55. Leiby D.A., Herron R.M., Read E.J., Lenes B.A., Stumpf R.J. Trypanosoma cruzi in Los Angeles and Miami blood donors: impact of evolving donor demographics on seroprevalence and implications for transfusion transmission. Transfusion 2002, 42:549-554.
56. Leiguarda M.D., Roncoroni A., Taratuto A.L., Jost L., Berthier M., Nogues M., et al. Acute CNS infection by Trypanosoma cruzi (Chagas' disease) in immunosuppressed patients. Neurology 1990, 40:850-851.
57. Levin M.J, Franco da Silveira J., Frasch A.C., Camargo M.E., Lafon S., Degrave W.M., Rangel-Aldao R., et al. Recombinant Trypanosoma cruzi antigens and Chagas' disease diagnosis: analysis of a workshop. FEMS Microbiol Immunol. 1991, 4:11-19.
58. Martin-Davila P., Fortún J., Lopez-Vélez R., Norman F., Montes de Oca M., Zamarrón R., et al. Transmission of tropical and geographically restricted infections during solid-organ transplantation. Clin. Microbiol. Rev. 2008, 21:60-96.
59. Mayer H.F. Infeccion experimental con Trypanosoma cruzi por via digestive. Anales Inst. Med. Regional 1961, 5:43-48.
60. Milei J., Mautner B., Storino R., Sanchez J.A., Ferrans V.J. Does Chagas' disease exist as an undiagnosed form of cardiomyopathy in the United States?. Am. Heart J. 1992, 123:1732-1735.
61. Moncayo A. Chagas disease: current epidemiological trends after the interruption of vectorial and transfusional transmission in the Southern Cone countries. Mem. Inst. Oswaldo Cruz 2003, 98(5):577-591.
62. Moncayo A., Silveira A.C. Current epidemiological trends for Chagas disease in Latin America and future challenges in epidemiology, surveillance and health policy. Mem. Inst. Oswaldo Cruz 2009, 104:17-30.
63. Moraes-Souza H., Pianetti G.M., Barretto O.C., Nonoyama K., Grolg M., Chiari E. Aminoquinolone WR6026 as a feasible substitute for gentian violet in Chagas' disease prophylaxis in preserved blood for transfusional purposes. Rev. Soc. Bras. Med. Trop. 2002, 35(6):563-569.
64. Nattan-Larrier L. Infections à Trypanosomes et voies de pénétrations des virus. Bull. Soc. Path. Exot. 1921, 26:257-259.
65. Navin T.R., Roberto R.R., Juranek D.D., Limpakarnjanarat K., Mortenson E.W., Clover J.R., et al. Human and sylvatic Trypanosoma cruzi infection in California. Am. J. Public Health 1985, 75:366-369.
66. Neves Pinto A.Y., Valente S.A, Valente V.C., Ferreira A.G., Coura J.R. Fase aguda da doença de Chagas na Amazônia brasileira. Estudo de 233 casos de pará, amapá e maranhão observados entre 1988 e 2005. Rev. Soc. Bras. Med. Trop. 2008, 41(6):602-614.
67. Nickerson P., Orr P., Schroeder M.L., Sekle L., Johnston J.B. Transfusion associated Trypanosoma cruzi infection in a nonendemic area. Ann. Intern. Med. 1989, 111:851-852.
68. Nóbrega A.A., Garcia M.H., Tatto E., Obara M.T., Costa E., Sobel J., et al. Oral transmission of Chagas disease by consumption of açaí palm fruit, Brazil. Emerg. Infect. Dis. 2009, 15(4):653-655.
69. Nussenzweig V., Sonntag R., Biancalana A., Pedreira de Freitas J.L., Amato Neto V., Kloetzel J. Action of certain dyes on T. cruzi in vitro. The use of gentian violet to prevent the transmission of Chagas' disease by blood transfusion. Hospital 1953, 44:731-744.
70. O'Brien S.F., Ram S.S., Vamvakas E.C., Goldman M. The Canadian blood donor health assessment questionnaire: lessons from history, application of cognitive science principles, and recommendations for change. Transfus. Med. Rev. 2007, 21:205-222.
71. «Informe» de la consulta técnica en epidemiologia, prevención y manejo de la transmission de la enfermedad de Chagas como enfermedad transmitida por alimentos (ETA). Consulta técnica en epidemiologia, prevenção e manejo de transmissão da doença de Chagas como doença transmitida por alimentos, PANAFTOSA, Rio de Janeiro, Brasil, 4 y 5 de mayo de 2006. Rev. Soc. Bras. Med. Trop. 2006, 39(5):512-514. OPS and OMS.
72. Pinto-Dias J.C. Nota sobre o Trypanosoma cruzi e suas características bio-ecológicas, como agente de enfermedades transmitidas por alimentos. Rev. Soc. Bras. Med. Trop. 2006, 39(4):370-375.
73. Pinto-Dias J.C., Brener Z. Chagas' disease and blood transfusion. Mem. Inst. Oswaldo Cruz 1984, 79:139-147.
74. Pirard M., Lihoshi N., Boelaert M., Basanta P., Lopez F., Van der Stuift P. The validity of the serologic tests for Trypanosoma cruzi and the effectiveness of transfusional screening strategies in a hyperendemic region. Transfusion 2005, 45:554-561.
75. Ponce C., Ponce E., Vinelli E., Montoya A., de Aguilar V., Gonzalez A., et al. Validation of a rapid and reliable test for diagnosis of Chagas disease by detection of Trypanosoma cruzi-specific antibodies in blood of donors and patients in Central America. J. Clin. Microbiol. 2005, 43:5065-5068.
76. ProMED-mail, 2007. Enf. De Chagas, via oral, brote escolar-Venezuela (05) ProMED-mail 2007; 23 Dec: 20071224.4125. (accessed 03.01.08). http://www.promedmail.org.
77. Reesink H.W. European strategies against the parasite transfusion risk. Transfus. Clin. Biol. 2005, 12(1):1-4.
78. Riarte A., Luna C., Sabatiello R., Sinagra A., Schiavelli R., De Rissio A., et al. Chagas' disease in patients with kidney transplants: 7 years of experience 1989-1996. Clin. Infect. Dis. 1999, 29:561-567.
79. Ribeiro D.R., Rissato e Garcia T.A., Bonomo W.C. Contribuição para o estudo dos mecanismos de transmissão do agente etiológico da doença de Chagas. Rev. Saude Publ. São Paulo 1987, 21(1):51-54.
80. Rivera J., Hillis L.D., Levine B.D. Reactivation of cardiac Chagas' disease in acquired immune deficiency syndrome. Am. J. Cardiol. 2004, 94:1102-1103.
81. Sartori A.M., Lopes M.H., Benvenuti L.A., Caramelli B., di Pietro A., Nunes E.V., et al. Reactivation of Chagas' disease in a human immunodeficiency virus-infected patient leading to severe heart disease with a late positive direct microscopic examination of the blood. Am. J. Trop. Med. Hyg. 1998, 59:784-786.
82. Sartori A.M., Ibrahim K.Y., Nunes Westphalen E.V., Braz L.M., Oliveira C.C., Gakiya E., et al. Manifestations of Chagas disease (American trypanosomiasis) in patients with HIV/AIDS. Ann. Trop. Med. Parasitol. 2007, 101:31-50.
83. Schenone H., Gonzalez H., Schenone H., Rojas A. Infección experimental de ratas con Trypanosoma cruzi por vía oral. Bol. Chile Parasit. 1982, 37:2-9.
84. Schmunis G.A. Trypanosoma cruzi, the etiologic agent of Chagas' disease: status in the blood supply in endemic and nonendemic countries. Transfusion 1991, 31:547-557.
85. Schmunis G.A. Prevention of transfusional T. cruzi infection in Latin America. Mem. Inst. Oswaldo Cruz 1999, 94:93-101.
86. Schmunis G.A. Epidemiology of Chagas disease in nonendemic countries: the role of international migration. Mem. Inst. Oswaldo Cruz 2007, 102:75-85.
87. Schmunis G.A., Cruz J.R. Safety of the blood supply in Latin America. Clin. Microbiol. Rev. 2005, 18:12-29.
88. Schmunis G.A., Yadon Z.E. Chagas disease: a Latin American health problem becoming a world health problem. Acta. Trop. 2009, 115:14-21.
89. Schmunis G.A., Zicker F., Pinheiro F., Cruz J.R., Cuchi P. Safety of blood supply for infectious diseases in Latin American countries, 1994-1997. Am. J. Trop. Med. Hyg. 2001, 65:924-930.
90. Shaw J., Lainson R., Frahia H. Considerações sobre a epidemiologia dos primeiros casos autoctones de doença de Chagas registrado em Belém, Pará, Brazil. Ver. Saude Publ. São Paulo 1969, 3:153-157.
91. Shikanai-Yasuda M.A., Marcondes C.B., Guedes L.A. Possible oral transmission of acute Chagas' disease in Brazil. Rev. Inst. Med. Trop. São Paulo 1991, 33:351-357.
92. Silva J.J.N., Osakabe A.L., Pavanelli W.R., Silva J.S., Franco D.W. In vitro and in vivo antiproliferative and trypanocidal activities of ruthenium NO donors. Br. J. Pharmacol. 2007, 152(1):112-121.
93. Silva N.N.da, Clausell D.T., Nolibos H., Mello A.L.de, Ossanai J., Raponte T., et al. Surto epidêmico de doença de Chagas com provãvel contaminação oral. Rev. Inst. Med. Trop. São Paulo 1968, 10(5):265-276.
94. Sousa F.F., Castro-e-Silva O., Marin-Neto J.A., Sankarankutty A.K., Teixeira A.C., Martinelli A.L.C., et al. Acute chagasic myocardiopathy after orthotopic liver transplantation with donor and recipient serologically negative for Trypanosoma cruzi: a case report. Transplant Proc. 2008, 40:875-878.
95. Steele L.S., MacPherson D.W., Kim J., Keystone J.S., Gushulak B.D. The sero-prevalence of antibodies to Trypanosoma cruzi in Latin American refugees and immigrants to Canada. J. Immigr. Minor. Health 2007, 9:43-47.
96. Streindel M., Kramer Pacheco L., Scholl D., Soares M., Moraes M.H., Eger I., et al. Characterization of Trypanosoma cruzi isolated from humans, vectors, and animals reservoirs following an outbreak of acute human Chagas disease in Santa Catarina State, Brazil. Diag. Microbiol. Infect. Dis. 2008, 60:25-32.
97. Talice R.V. Enfermedades Parasitarias del Hombre y Parásitos de Interés Medico 1944, Monteverde, Montevideo Ed., v.1.
98. Torrico R.A. Conocimientos actuales sobre la enfermedad de Chagas en Bolivia. Bol. Of. Sanit. Panam. 1950, 29:827-841.
99. Ueno Y., Nakamura Y., Takabashi M., Inoue T., Endo S., Kinoshita M., et al. A highly suspected case of chronic Chagas heart disease diagnosed in Japan. Jpn. Circ. J. 1995, 59:219-223.
100. Umezawa E.S., Luquetti A.O., Levitus G., Ponce C., Ponce E., Henriquez D., et al. Serodiagnosis of chronic and acute Chagas' disease with Trypanosoma cruzi recombinant proteins: results of a collaborative study in six Latin America countries. J. Clin. Microbiol. 2004, 42:449-452.
101. Valente S.A.S., Valente V.C., Fraiha Neto H. Transmissão da doença de Chagas: como estamos? Considerações sobre a epidemiologia e transmissão da doença de Chagas na Amazônia Brasiliera. Rev. Soc. Bras. Med. Trop. 1999, 32(Suppl. 2):51-55.
102. Valente S.A.S., Valente V.C., Pin A.Y. Epidemiologia e transmissão oral da doença de Chagas na Amazônia Brasiliera. In: Informe de la Consulta Técnica em Epidemiologia, Prevencion y Manejo de la Transmission de la Enfermedad de Chagas como Enfermedad Transmitida por Alimentos (ETA). 2006, Organizacion Panamericana de la Salud/Organizacion Mundial de la Salud, Washington, pp. 21-26.
103. Verani J.R., Seitz A., Gilman R.H., La Fuente C., Galdos-Cardenas G., Kawai V., et al. Geographic variation in the sensitivity of recombinant antigen-based rapid tests for chronic Trypanosoma cruzi infection. Am. J. Trop. Med. Hyg. 2009, 80(3):410-415.
104. Vergara U., Veloso C., Gonzalez A., Lorca M., et al. Evaluation of an enzyme-linked immunosorbent assay for the diagnosis of Chagas' disease using synthetic peptides. Am. J. Trop. Med. Hyg. 1992, 46:39-43.
105. Wendel S. Transfusion transmitted Chagas disease: is it really under control?. Acta. Trop. 2010, 115:28-34.
106. Wincker P., Britto C., Borges Pereira J., Cardoso M.A., Oeleman W., Morel C. Use of simplified polymerase chain reaction procedure to detect Trypanosoma cruzi in blood samples from chronic chagasic patients in a rural endemic area. Am. J. Trop. Med. Hyg. 1994, 51:771-777.
107. Wincker P., Telleria J., Bosseno M.F., Cardoso M.A., Marques P., Yaksic N., Aznar C., Liegeard P., Hontebeyrie M., Noireau F., Morel C.M., Brenière S.F., et al. PCR-based diagnosis for Chagas' disease in Bolivian children living in an active transmission area: comparison with conventional serological and parasitological diagnosis. Parasitology 1997, 114:367-373.
108. Young C., Losikoff P., Chawla A., Glasser L., Forman E. Transfusion-acquired Trypanosoma cruzi infection. Transfusion 2007, 47:540-544.